This nationwide cohort study provides updated insights into the incidence of unaffected BRCA1/2 carriers, BRRM and RR-BSO uptake, and their impact on breast cancer risk and mortality in Denmark, also compared with the general population. The gene discussed is BRCA1; the disease is breast carcinoma.